108 results
8-K
PFE
Pfizer Inc.
22 May 24
Cost Associated with Exit or Disposal Activities
12:39pm
, retention issues or other unintended consequences; disruptions in the relationships between us and our collaboration partners or third-party suppliers
8-K
EX-99
PFE
Pfizer Inc.
1 May 24
Pfizer Reports First-Quarter 2024 Results
8:11am
in unexpected costs, organizational disruption, adverse effects on employee morale, retention issues or other unintended consequences;
the ability
8-K
EX-99
gkknxj 1j
30 Jan 24
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
8:04am
8-K
EX-1.1
871ev82v5yzz1 60k818
19 May 23
Other Events
4:26pm
8-K
EX-1.1
vegfsb3 r17omk
18 Aug 21
Other Events
4:06pm
8-K
ls5lpocriwvp
13 Nov 20
Unregistered Sales of Equity Securities
5:05pm
8-K
EX-99.1
i9urga03
5 Nov 20
Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock
4:42pm
8-K
EX-99.1
y12i0uwt5xb86b87v
30 Oct 20
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn
5:10pm
8-K
dyc8jl0 wxxs6
6 Aug 20
Regulation FD Disclosure
5:23pm
8-K
EX-99.1
3on6np ohwcuahap90tm
6 Aug 20
Regulation FD Disclosure
5:23pm
425
h2ee xdq6zcmz
26 Jun 20
Business combination disclosure
5:05pm
8-K
gsc7dg0 j89
26 Jun 20
Other Events
5:03pm
425
bhc4dx
18 Jun 20
Business combination disclosure
5:01pm
425
i5xonfn 07nlnn2nf0
1 Jun 20
Business combination disclosure
5:27pm
8-K
nylyj233iosj
1 Jun 20
Entry into a Material Definitive Agreement
5:25pm